Correlation Between Century Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Century Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Century Therapeutics and Entero Therapeutics,
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Century and Entero is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Century Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Century Therapeutics is expected to generate 0.53 times more return on investment than Entero Therapeutics,. However, Century Therapeutics is 1.89 times less risky than Entero Therapeutics,. It trades about -0.04 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 927.00 in Century Therapeutics on August 30, 2024 and sell it today you would lose (764.00) from holding Century Therapeutics or give up 82.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Entero Therapeutics,
Performance |
| Timeline |
| Century Therapeutics |
| Entero Therapeutics, |
Century Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Century Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
| Entero Therapeutics, vs. Unilever PLC ADR | Entero Therapeutics, vs. American Axle Manufacturing | Entero Therapeutics, vs. PACCAR Inc | Entero Therapeutics, vs. Weyco Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |